USFDA approves Glenmark PharmaIllustrative image – not actual.

Glenmark Pharmaceuticals has received an approval from USFDA (US Food and Drug Administration) for marketing anti-diarrheal drug Crofelemer through Salix Pharmaceuticals.

Crofelemer is used to relieve symptoms of diarrhea in HIV/AIDS patients undergoing anti-retroviral therapy. Glenmark will be the active pharmaceutical ingredients supplier for the drug to Salix in regulated markets.

Source: Business Standard


 

← All latest storiesBack to top →